The Food and Drug Administration is expected to authorized the use of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds by next week, The New York Times reports.
Why it matters: Opening up vaccine eligibility to young people and children will be crucial as the U.S. works to achieve herd immunity.
The big picture: The FDA approval for teens could come in early next week or even sooner, per AP.
- The agency is also expected to approve the vaccine for even younger children in the fall.
- Pfizer has said its vaccine was 100% effective at protecting against COVID-19 in a trial of more than 2,200 children between the ages of 12 and 15.